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Abstract
Background: The use of surface electromyography has been accepted as a valid, non-invasive measure of
neuromuscular fatigue. In particular, the electromyographic fatigue threshold test (EMGFT) is a reliable
submaximal tool to identify the onset of fatigue. This study examined the metabolic relationship between VO2PEAK,
ventilatory threshold (VT), and the EMGFT, as well as compared the power output at VO2PEAK, VT, and EMGFT.
Methods: Thirty-eight college-aged males (mean ± SD = 22.5 ± 3.5 yrs) performed an incremental test to
exhaustion on an electronically-braked cycle ergometer for the determination of VO2PEAK and VT. Each subject
also performed a discontinuous incremental cycle ergometer test to determine their EMGFT value, determined
from bipolar surface electrodes placed on the longitudinal axis of the vastus lateralis of the right thigh. Subjects
completed a total of four, 2-minute work bouts (ranging from 75–325 W). Adequate rest was given between
bouts to allow for subjects' heart rate to drop within 10 beats of their resting heart rate. The EMG amplitude was
averaged over 10-second intervals and plotted over the 2-minute work bout. The resulting slopes from each
successive work bout were used to calculate EMGFT.
Results: Power outputs and VO2 values from each subject's incremental test to exhaustion were regressed. The
linear equations were used to compute the VO2 value that corresponded to each fatigue threshold. Two separate
one-way repeated measure ANOVAs indicated significant differences (p < 0.05) among metabolic parameters and
power outputs. However, the mean metabolic values for VT (1.90 ± 0.50 l·min-1) and EMGFTVO2(1.84 ± 0.53
l·min-1) were not significantly different (p > 0.05) and were highly correlated (r = 0.750). Furthermore, the mean
workload at VT was 130.7 ± 37.8 W compared with 134.1 ± 43.5 W at EMGFT (p > 0.05) with a strong correlation
between the two variables (r = 0.766).
Conclusion: Metabolic measurements, as well as the power outputs at VT and EMGFT, were strongly correlated.
The significant relationship between VT and EMGFT suggests that both procedures may reflect similar physiological
factors associated with the onset of fatigue. As a result of these findings, the EMGFT test may provide an attractive
alternative to estimating VT.
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Background
Matsumoto et al. [1] and Moritani et al. [2] have proposed
an incremental cycle ergometer test utilizing fatigue curves
to identify the maximal power output at which an individ-
ual can maintain without evidence of fatigue, described as
the electromyographic fatigue threshold (EMGFT). The
EMGFT  test is an adaptation to deVries' [3] original
monopolar physical working capacity at the fatigue
threshold (PWCFT) test, using a bipolar supramaximal
protocol. The EMGFT involves determining the rate of rise
in electrical activity from the vastus lateralis during four,
two-minute work bouts on a cycle ergometer, with varying
power outputs. It has been suggested that the rise in elec-
trical activity is a result of progressive recruitment of addi-
tional motor units (MU) and/or an increase in the firing
frequency of MUs that have already been recruited. Sev-
eral investigations have used surface electromyography to
characterize the fatigue-induced increase in EMG ampli-
tude, as well as to identify the power output associated
with the onset of neuromuscular fatigue during cycle
ergometry [1,2,4-8]. Matsumoto et al. [1] described the
EMGFT as the highest intensity sustainable on a cycle
ergometer without signs of neuromuscular fatigue. In
addition, Moritani et al. [2] suggested a strong physiolog-
ical link between myoelectrical changes at fatigue and
anaerobic threshold. Furthermore, the EMGFT method has
been reported as a valid and reliable technique for exam-
ining the transition from aerobic to anaerobic metabo-
lism during exercise [4,6,7]. Identifying a reliable, non-
invasive way to measure and predict the onset of fatigue
has potential use in clinical populations, as well as serving
as a training tool for those with minimal testing equip-
ment. Therefore, the purpose of this study was to examine
the metabolic relationship between VO2PEAK, ventilatory
threshold (VT), and the EMGFT, as well as to compare the
power output at VO2PEAK, VT, and EMGFT.
Methods
Participants
Thirty-eight recreationally trained (1–5 hours/week), col-
lege-aged men (Table 1) volunteered to participate in this
study. All procedures were approved by the University of
Oklahoma Institutional Review Board for Human Sub-
jects, and written informed consent was obtained from
each participant prior to any testing.
Determination of VO2PEAK and Ventilatory Threshold
Participants performed a continuous graded exercise test
(GXT) on an electronically-braked cycle ergometer
(Corival Lode 400, Groningen, The Netherlands) to deter-
mine maximal oxygen consumption (VO2PEAK) and venti-
latory threshold (VT). Following a five-minute warm-up
(50 W), the workload was increased 25 W every two min-
utes until the participants were unable to maintain 70
rpm, or until volitional fatigue.
Ventilatory threshold was determined as a plot of ventila-
tion (VE) vs. oxygen consumption (VO2), as described pre-
viously [9]. Two linear regression lines were fit to the
lower and upper portions of the VE vs. VO2 curve before
and after the break points, respectively. The intersection of
these two lines was defined as VT.
Gas Exchange Analysis
Open circuit spirometry was used to analyze the gas
exchange data using the Parvo-Medics TrueOne 2400®
Metabolic Measurement System (Sandy, Utah, United
States). Oxygen and carbon dioxide were analyzed
through a sampling line after the gases passed through a
heated pneumotach and mixing chamber. The data were
averaged over 15-second intervals. The highest average
VO2 value during the GXT was recorded as the VO2PEAK if
it coincided with at least two of the following criteria: (a)
a plateau in heart rate (HR) or HR values within 10% of
the age-predicted HRmax, (b) a plateau in VO2 (defined
by an increase of no more than 150 ml·min-1), and/or (c)
an RER value greater than 1.15 [10].
Electromyography
Pre-gelled bipolar (2.54 cm center-to-center) surface elec-
trodes (Ag-Ag Cl, Quinton Quick Prep, Quinton Instru-
ments Co., Bothell, WA) were placed over the lateral
portion of the vastus lateralis muscle, midway between
the greater trochanter and the lateral condyle of the femur.
A reference electrode was placed over the 7th cervical ver-
tebrae. The raw EMG signals were pre-amplified ((gain ×
1,000) EMG 100C, Biopac Systems, Inc., Santa Barbara,
CA), sampled at 1,000 Hz and bandpass filtered from 10–
500 Hz (zero-lag 8th order Butterworth filter). All EMG
amplitude values were stored on a personal computer
(Dell Inspiron 8200, Dell, Inc., Round Rock, TX) and ana-
lyzed off-line using custom-written software (LabVIEW v
7.1, National Instruments, Austin, TX).
Determination of the EMGFT
Participants returned 24–48 hours after the GXT to per-
form the EMGFT test. Following a five-minute warm-up on
an electronically-braked cycle ergometer (Quinton
Corival 400), participants completed four two-minute
cycling bouts at incrementally ascending workloads (75
W–300 W). The initial workload corresponded with the
Table 1: Descriptive statistics (mean ± SD) of the subjects.
Subjects (n = 35)
Age (yrs) 22.6 ± 3.5
Height (cm) 177.1 ± 7.1
Weight (kg) 77.0 ± 11.0Dynamic Medicine 2008, 7:15 http://www.dynamic-med.com/content/7/1/15
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workload at which VT occurred, determined during the
GXT. Adequate rest was given between bouts to allow for
participants' heart rate to drop within 10 beats of their
resting heart rate. The rate of rise in EMG amplitude values
(EMG slope) from the four workloads were plotted over
120 seconds (Figure 1a). The EMG slope values for each of
the four power outputs were then plotted to determine
EMGFT (Figure 1b). The line of best fit was extrapolated to
the y-axis, and the power output at which it intersected the
y-axis was defined as the EMGFT. The participants com-
pleted the EMGFT protocol two times; familiarization trial
and baseline.
Test-rest reliability for the EMGFT protocol, determined at
the University of Oklahoma, resulted in an intraclass cor-
relation coefficient (ICC) of 0.935 (SEM 5.03 W). The ICC
from this lab was higher than previously reported using
the vastus lateralis (ICC = 0.65) [11].
Statistical Analysis
Each participant's power outputs from the EMGFT and the
VO2PEAK corresponding to the outputs during the GXT
were regressed. A linear equation was developed to predict
the VO2  value that corresponded to the EMGFT
(EMGFTVO2). A one-way repeated measures ANOVA was
used to determine differences between the EMGFTVO2, VT,
and VO2PEAK. When appropriate, follow-up dependent t-
test analyses were run. Correlation analyses were run to
determine the strength of the relationship between EMGFT
vs. VT (watts) and EMGFTVO2 vs. VT (l·min-1). All data are
reported as mean ± S.E.
Results
A one-way repeated measures analysis of variance
(ANOVA) indicated a significant (p < 0.001) difference
among metabolic parameters for EMGFTVO2, VT, and
VO2PEAK. Table 2 presents the mean metabolic and power
output values for EMGFT and VT, as well as the correlation
coefficients for these variables. Dependent t-test analyses
resulted in no significant differences (p = 0.794) between
the power output at which EMGFT and VT occurred, as well
as no significant differences (p = 0.204) between the
EMGFTVO2 and VT. However, the VO2PEAK values were sig-
nificantly different from both parameters. Furthermore,
power output and metabolic parameters for EMGFT and
VT were strongly correlated (r = 0.766 and r = 0.750,
respectively). Figure 2 displays the relationship between
EMGFT and VT parameters for mean power output (W)
and metabolic values (l·min-1). Based on significant cor-
relation analysis (Table 2), a regression equation was
developed to predict VT from EMGFT which resulted in a
strong relationship with a low (less than 4% of mean)
standard error of estimate (SEE):
VT (W) = 0.665(EMGFT) + 41.53; SEE = 13 W
Discussion
The results of the present study demonstrated support for
previous work verifying the use of the EMGFT as a reliable
and non-invasive method for identifying the onset of neu-
romuscular fatigue [1-7]. In addition, a highly significant
relationship between power output values at EMGFT and
VT was found. Furthermore, no significant difference
between metabolic values at EMGFTVO2  and VT was
found. Several studies have suggested the use of the
EMGFT as a simple and attractive alternative to identify the
onset of fatigue [1-3,6,7,12]. The results of the current
study further support the myoelectrical and physiological
similarities proposed between the EMGFT and VT.
The EMGFT theoretically represents the highest power out-
put that can be sustained without electromyographic evi-
dence of neuromuscular fatigue [1,2]. In addition, the VT
has been proposed to correlate with a workload that the-
oretically can be maintained without evidence of fatigue
[7]. The VT may be an indicator of the ability of the cardi-
ovascular system to adequately supply oxygen to the
working muscles to prevent muscle anaerobisis [13]. Per-
Determination of EMGFT Figure 1
Determination of EMGFT. a. Describes the relationship 
between EMG amplitude and time for the four power out-
puts used in the EMGFT test. The greatest slope was a result 
from the highest power output. b. Depicts the relationship 
for the power outputs versus slope coefficients with the y-
intercept defined as the EMGFT.
a.
b.Dynamic Medicine 2008, 7:15 http://www.dynamic-med.com/content/7/1/15
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forming exercise at an intensity greater than the VT would
result in an inadequate supply of oxygen to the working
muscle, resulting in the recruitment of Type II muscle fib-
ers, quickly leading to fatigue [13]. The fatigued state of a
muscle has been associated with changes in motor unit
recruitment and/or changes in the frequency of motor
unit firing resulting in an increase in EMG activity [8]. Sev-
eral studies have proposed a strong physiological relation-
ship between VT and the onset of neuromuscular fatigue,
with both measures representing recruitment of Type II
muscle fibers due to the transition from aerobic to anaer-
obic metabolism [3,4,6,8,14]. As a result, there would be
an increase in muscle lactate concentration corresponding
to a decrease skeletal muscle pH, which may further signal
arterial chemoreceptors that alter ventilatory regulating
mechanisms [15-17]. The evidence presented in this study
suggests that the EMGFT and VT may reflect similar acute
physiological adaptations that occur during exercise.
The data in the present study are in agreement with previ-
ous investigations that have reported VT and EMGFT to
occur at similar power outputs during cycle ergometry
[1,3,7,8,12]. In addition, the current study provides new
data indicating no significant difference between the VT
and EMGFTVO2. In contrast, Moritani et al. determined
EMGFTVO2 by calculating each participant's delta mechan-
ical efficiency values [2], as described by Gaesser and
Brooks [18], during the incremental exercise test.
Although Moritani et al. reported a significant difference
between VT and EMGFTVO2 using the delta mechanical
efficiency technique, Gaesser and Brooks determined that
this technique was not valid. However, the significant
relationships (Table 2) between VT vs. EMGFT and VT vs.
EMGFTVO2 found in the present study suggest the possi-
bility of using EMGFT, rather than gas analysis, to predict
VT. Based on this assumption, a regression equation was
developed to predict VT from EMGFT: VT (W) =
0.665(EMGFT) + 41.53; SEE = 13 W. The strong correlation
and low prediction error (SEE < 4.0%) indicate that the
EMGFT test may be an alternative and salient method to
predict VT.
Table 2: Mean ± standard error (SE) values and correlations for EMGFT and VT.
Correlation analysis
Mean ± SEM (l-min-1) Mean ± SEM (W) EMGFT(l-min-1)E M G FT(W)
Electromyographic Fatigue Threshold 1.84 ± 0.09 134.11 ± 7.06 1.000 1.000
Ventilatory Threshold 1.89 ± 0.08 130.71 ± 6.13 0.750* 0.766*
*p < 0.01
Comparison of EMGFT and VT Figure 2
Comparison of EMGFT and VT. The relationship between differences in EMGFT and VT mean power outputs (W) and met-
abolic values (l·min-1).
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Conclusion
In summary, the relationship between VT and EMGFTVO2
suggests a possible attractive alternative to measuring VT
via gas analysis. Determining VT using gas analysis
requires participants to reach volitional fatigue during a
graded exercise test, and, therefore, the results may be
influenced by motivation. The EMGFT test consists of sub-
maximal workloads which should eliminate the influence
of participant motivation. In addition, due to the submax-
imal nature of the test, it may provide a safe alternative to
determining VT for clinical populations in which maximal
exertion may not be safe. Furthermore, the EMGFT test
may reduce or eliminate discomfort experienced during
gas analysis due to the gas measurement equipment.
However, additional studies are needed to validate the
regression equation proposed in the present study to pre-
dict VT using EMGFT. In addition, future studies are war-
ranted to determine whether the regression equation can
accurately track changes in VT over time with training.
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